References
- Enterina JR, Jung J, Macauley MS. Coordinated roles for glycans in regulating the inhibitory function of CD22 on B cells. Biomed J. 2019; 42(4):1–4. doi: 10.1016/j.bj.2019.07.010.
- Yanaba K, Bouaziz JD, Haas KM, et al. A regulatory B cell subset with a unique CD1dhi CD5+ phenotype controls T cell-dependent inflammatory responses. Immunity. 2008;28(5):639–650. doi: 10.1016/j.immuni.2008.03.017.
- DiLillo DJ, Matsushita T, Tedder TF. B10 cells and regulatory B cells balance immune responses during inflammation, autoimmunity, and cancer. Ann N Y Acad Sci. 2010;1183(1):38–57. doi: 10.1111/j.1749-6632.2009.05137.x.
- Yoshizaki A, Miyagaki T, DiLillo DJ, et al. Regulatory B cells control T-cell autoimmunity through IL-21-dependent cognate interactions. Nature. 2012;491(7423):264–268. doi: 10.1038/nature11501.
- Tung JW, Mrazek MD, Yang Y, et al. Phenotypically distinct B cell development pathways map to the three B cell lineages in the mouse. Proc Natl Acad Sci USA. 2006;103(16):6293–6298. doi: 10.1073/pnas.0511305103.
- Yanaba K, Kamata M, Asano Y, et al. CD19 expression in B cells regulates atopic dermatitis in a mouse model. Am J Pathol. 2013;182:2212–2222.
- Čelakovská J, Bukač J, Cermákova E, et al. Analysis of results of specific IgE in 100 atopic dermatitis patients with the use of multiplex examination ALEX2-Allergy explorer. Int J Mol Sci. 2021;22(10):5286. PMID: 34067936; PMCID: PMC8156228. doi: 10.3390/ijms22105286.
- Ahn J, Choi Y, Simpson EL. Therapeutic new era for atopic dermatitis: Part 1. Biologics. Ann Dermatol. 2021;33(1):1–10. doi: 10.5021/ad.2021.33.1.1.